Notes
The use of tradenames is for product identification purposes only and does not imply endorsement.
References
Goldsmith DR, Wagstaff AJ, Ibbotson T, et al. Lamotrigine: a review of its use in bipolar disorder. Drugs 2003; 63 (19): 2029–50.
Malhi GS, Mitchell PB, Salim S. Bipolar depression: management options. CNS Drugs 2003; 17 (1): 9–25.
Strakowski SM, DelBello MP, Adler CM. Comparative efficacy and tolerability of drug treatments for bipolar disorder. CNS Drugs 2001; 15 (9): 701–18.
Hirschfeld RMA, Bowden CL, Gitlin MJ, et al. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002 Apr; 159 (4 Suppl.): 1–50
Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003 Sep; 64 (9): 1013–24.
Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003 Apr; 60 (4): 392–400.
Calabrese JR, Bowden CL, Fieve R, et al. Lamotrigine or lithium in the maintenance treatment of bipolar I disorder [abstract no. P.1. 115]. Eur Neuropsychopharmacol 2002; 12 Suppl. 3: S217.
Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000 Nov; 61 (11): 841–50.
Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. J Clin Psychiatry 1999 Feb; 60 (2): 79–88.
Frye MA, Ketter TA, Kimbrell TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000 Dec; 20 (6): 607–14.
Prescribing information: Lamictal (lamotrigine) [online]. Available from URL: http://us.gsk.com/products/assets/uslamictal.pdf [Accessed 2003 Nov 20]
Ginsberg L, Sachs G, Ketter T, et al. Effects of mood stabilizers on body weight in bipolar I disorder [abstract no. NR463 plus poster]. American Psychiatric Association 2003 Annual Meeting: New Research Abstracts; 2003 May 17, 4
Calabrese JR, Sullivan JR, Bowden CL, et al. Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiatry 2002 Nov; 63 (11): 1012–9.
Rights and permissions
About this article
Cite this article
Lamotrigine as maintenance therapy in bipolar I disorder exerts beneficial effects predominantly on the depressive phase. Drugs Ther. Perspect 20, 1–4 (2004). https://doi.org/10.2165/00042310-200420030-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200420030-00001